Table 1 Demographics and Baseline BMD Values
Characteristic, mean (SD) unless otherwise specified | Secukinumab (N = 104) |
|---|---|
Age (years) | 40.4 (12.3) |
Male, n (%) | 69 (66.3) |
Caucasian, n (%) | 61 (58.7) |
BMI (kg/m2) | 26.1 (4.8) |
Time since AS diagnosis (years) | 6.4 (7.1) |
Lumbar spine BMD (g/cm2) | 1.026 (0.2) |
Hip BMD (g/cm2) | 0.902 (0.2) |
Femoral neck BMD (g/cm2) | 0.819 (0.2) |
Lumbar spine BMD T-Score | −0.6 (1.6) |
Hip BMD T-Score | −0.5 (1.2) |
Femoral neck BMD T-Score | −0.8 (1.1) |
Lumbar spine BMD Z-Score | −0.8 (1.6) |
Hip BMD Z-Score | −0.6 (1.1) |
Femoral neck BMD Z-Score | −0.6 (1.0) |